Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies.
2024/4/25 16:16:55
(TPTX:NASDAQ)
Streetwise Reports Articles